Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 #mds #pharma #services

Posted On Aug 19 2017 by

#pharmaceutical industry overview 2013 # Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 Life sciences companies face unprecedented challenges as revenues come under pressure as a consequence of pricing pressures caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market. They are responding by focusing on growth opportunities in emerging markets, pursuing breakthrough innovation through collaboration with industry and academic partners, challenging and revolutionizing the traditional sales, marketing and research and development (R D) operating models and focusing on operational efficiency. Shifts in the behavior of patients …


Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #leading

Posted On Aug 19 2017 by

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …


Top 10 animal health companies of 2013 #ucb #pharma #inc

Posted On Aug 5 2017 by

#leading pharmaceutical companies 2013 # Top 10 animal health companies of 2013 It is fascinating what has happened in the last couple of years in the animal health industry, which runs to $22 billion a year for animal drugs and vaccines and is expected to grow at 5.7% compound annual rate, faster than the market for human medicines. Zoetis ($ZTS) was spun off from Pfizer ($PFE) as the largest independent animal health company. M A action in recent months is remixing the players once again. Next year, Novartis ($NVS) will be off of this list, and based on current revenues, …


2013 so far: the pharmaceutical products making headway in the UK #pharma #bio

Posted On Aug 4 2017 by

#pharmaceutical products # The pharmaceutical products set to make headway in the UK market, 2013 In the last few decades it s been widely reported that the UK s contribution to new pharmaceutical products has steadily declined overall, but last year broke the trend with a record-breaking 39 projects approved. The biggest slump in relatively recent times was in 1985 when only 11 new products went to market, and activity peaked in 1997 and again in 2010 with 34 product launches respectively. A detailed description of activity can be found here. This year, a new wave of medicines to treat …


Pharmaceutical Industry Outlook 2013, Life Sciences Industry Outlook 2013 #top #10 #pharma

Posted On Aug 4 2017 by

#pharmaceutical industry overview 2013 # Biopharma Life Sciences Outlook 2013 What are the Biggest Challenges and Opportunities Facing the Biopharma Life Sciences Industry During the Next Year? Pharma executives need to carefully consider their approach as they work to improve health economics and patient outcomes. To address unyielding pricing pressures and the enhanced requirement for clinical innovation, pharma companies should calibrate their drug development life cycle to select drug candidates early in the life cycle based on efficacy and economics, provide the evidence for approval and favorable reimbursements, and maintain a strong market position through post-launch evidence. This is especially …


The top 10 most expensive drugs of 2013 #nutra #pharma

Posted On Aug 3 2017 by

#pharmaceutical companies news # The top 10 most expensive drugs of 2013 The price of Gilead Sciences’ breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, Gilead Sciences ($GILD) has been pilloried by politicians, payers and providers. But as EvaluatePharma points out, at that price Sovaldi barely makes it into the top 20 most expensive drugs. number 19 to be exact, just above Novartis’ ($NVS) Gleevec and just below GlaxoSmithKline’s ($GSK) Mekinist. Sovaldi is pricey, but if you want to talk about really pricey, then look at the 10 …


The top 10 pharma companies by 2013 revenue #healthcare #news

Posted On Aug 3 2017 by

#top pharma companies 2013 # The top 10 pharma companies by 2013 revenue The earnings reports for the biggest of Big Pharma are all in. Bayer reported last week, making it possible to see how they stacked up as they came into the new year. There are no big surprises. Pfizer ($PFE) and Merck Co. ($MRK), with ongoing patent issues and reorganizations, saw their positions fall a couple of notches, and AbbVie ($ABBV), having been spun off from Abbott Laboratories ($ABT) at the beginning of the year, didn’t quite make the top 10. Its disappearance allowed Eli Lilly Co. ($LLY) …


2013 Chevrolet Malibu Eco vs #2013 #chevrolet #malibu #eco #vs. #2012 #honda #accord #ex-l, #2012

Posted On Aug 2 2017 by

# 2012 Honda Accord EX-L A 10Best victor 26 times, the Accord has pretty much exhausted all of the glowing adjectives that D. Webster ever cataloged. The descriptor that characterizes the car right now, however, is aging. Until we tackled our handling loop, in fact, the Accord felt like a midpack finisher. Its transmission offers only five speeds. It tied with the Camry for dullest cockpit styling. Its 190-hp engine churns out the least torque. There s no exterior latch to open the trunk. And it proved the noisiest at full throttle a barrage of intake roar and singing belts …


Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #big

Posted On Jul 25 2017 by

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …


Top pharma companies 2013 #generic #pharmaceuticals #companies

Posted On Jul 25 2017 by

#top pharma companies 2013 # Novartis 2. Novartis 2013 revenue: $57.920 billion 2012 revenue: $56.673 billion As meager as 2% is, Novartis ($NVS) was among the companies on this year’s list to post growth. The pharma division beat that a bit with a 3% improvement. But with last year’s changing of the guard in the boardroom, the top dogs say that is not enough, and so an effort is on to get the drugmaker more focused on the areas most likely to grow more quickly. That means either selling or bolstering some of the units assembled under the previous administration, …